Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Change in Inventory: 2020-2025

Historic Change in Inventory for Beauty Health (SKIN) over the last 5 years, with Sep 2025 value amounting to -$2.0 million.

  • Beauty Health's Change in Inventory fell 326.00% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.1 million, marking a year-over-year decrease of 124.12%. This contributed to the annual value of $10.5 million for FY2024, which is 53.57% down from last year.
  • Per Beauty Health's latest filing, its Change in Inventory stood at -$2.0 million for Q3 2025, which was up 61.99% from -$5.3 million recorded in Q2 2025.
  • Beauty Health's 5-year Change in Inventory high stood at $33.5 million for Q3 2022, and its period low was -$11.3 million during Q2 2023.
  • Its 3-year average for Change in Inventory is $2.0 million, with a median of -$2.0 million in 2025.
  • Its Change in Inventory has fluctuated over the past 5 years, first surged by 1,552.74% in 2022, then slumped by 326.00% in 2025.
  • Over the past 5 years, Beauty Health's Change in Inventory (Quarterly) stood at $4.8 million in 2021, then soared by 155.46% to $12.2 million in 2022, then spiked by 112.87% to $26.0 million in 2023, then tumbled by 88.36% to $3.0 million in 2024, then tumbled by 326.00% to -$2.0 million in 2025.
  • Its Change in Inventory stands at -$2.0 million for Q3 2025, versus -$5.3 million for Q2 2025 and -$3.8 million for Q1 2025.